Gyre Therapeutics
GYRE
#4873
Rank
S$2.00 B
Marketcap
$21.45
Share price
-4.70%
Change (1 day)
75.24%
Change (1 year)

EPS for Gyre Therapeutics (GYRE)

EPS in 2024 (TTM): $0.14

According to Gyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.89. In 2023 the company made an earnings per share (EPS) of -$1.89 a decrease over its 2022 EPS that were of $0.005839.

EPS history for Gyre Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)$0.14-107.63%
2023-$1.89-32451.8%
2022$0.005839-90.93%
2021$0.06434